Pipex Pharmaceuticals Completes Type A Meeting With FDA for Oral … - CNNMoney.com

Written by Admin on February 29th, 2008 in Uncategorized.

Pipex Pharmaceuticals Completes Type A Meeting With FDA for Oral
CNNMoney.com -7 hours ago
In order to enhance a resubmitted NDA filing for oral tetrathiomolybdate for the treatment of neurologic Wilson's disease, at the recent meeting Pipex

More: continued here

Leave a Reply



Site Navigation